FORMULATION PARAMETERS OF FLUOROQUINOLONE-LOADED LIPOSOMES AND IN-VITRO ANTIMICROBIAL ACTIVITY

被引:39
作者
PUGLISI, G
FRESTA, M
MAZZONE, G
FURNERI, PM
TEMPERA, G
机构
[1] ETH ZENTRUM, INST POLYMERE, CH-8092 ZURICH, SWITZERLAND
[2] UNIV CATANIA, IST MICROBIOL, CATANIA, ITALY
关键词
OFLOXACIN; PENFLOXACIN; LIPOSOME; ENCAPSULATION CAPACITY; RELEASE RATE; ANTIMICROBIAL ACTIVITY;
D O I
10.1016/0378-5173(94)00340-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To load pefloxacin and ofloxacin in liposomes, two preparation procedures were carried out, leading to the formation of multilamellar vesicles (MLVs) or reverse-phase evaporation vesicles (REVs). MLVs were able to entrap greater amounts of the two drugs than REVs, especially when the drugs were co-dissolved with the lipid mixture in the organic phase. The encapsulation efficiency was influenced by the presence of a negatively charged lipid in the liposome composition: the greater the content of charged lipidic compound, the larger is the amount of drug entrapped, Among the charged systems, a dipalmitoylphosphatidylcholine-cholesterol-dihexadecyl phosphate mixture (4:3:4 molar ratio) showed the highest trapping capacity. The fluidity of the bilayer could also influence the encapsulation efficiency. In fact, the increase in encapsulation capacity for the lecithin-cholesterol-dihexadecyl phosphate mixture (4:3:4 molar ratio) conformed to the following order: dipalmitoylphosphatidylcholine > dimyristoylphosphatidylcholine > egg phosphatidylcholine. Variation in pH values led to different encapsulation efficiency and release rate. In vitro experiments on the antimicrobial activity of the encapsulated fluroquinolones compared to the free drug demonstrated a reduction of at least 50% of the minimal inhibitory concentration.
引用
收藏
页码:65 / 76
页数:12
相关论文
共 27 条
[1]   PREPARATION AND CHARACTERIZATION OF MONODISPERSE UNILAMELLAR PHOSPHOLIPID-VESICLES WITH SELECTED DIAMETERS OF FROM 300 TO 600 NM [J].
AURORA, TS ;
LI, W ;
CUMMINS, HZ ;
HAINES, TH .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 820 (02) :250-258
[2]  
AYOMA H, 1987, ANTIMICROB AGENTS CH, V31, P1640
[3]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[4]   INFLUENCE OF POLYBUTYLCYANOACRYLATE NANOPARTICLES AND LIPOSOMES ON THE EFFICACY AND TOXICITY OF THE ANTICANCER DRUG MITOXANTRONE IN MURINE TUMOR-MODELS [J].
BECK, P ;
KREUTER, J ;
RESZKA, R ;
FICHTNER, I .
JOURNAL OF MICROENCAPSULATION, 1993, 10 (01) :101-114
[5]   INTERACTION OF THE FLUOROQUINOLONE ANTIMICROBIAL AGENTS CIPROFLOXACIN AND ENOXACIN WITH LIPOSOMES [J].
BEDARD, J ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1379-1382
[6]   ACCUMULATION OF ENOXACIN BY ESCHERICHIA-COLI AND BACILLUS-SUBTILIS [J].
BEDARD, J ;
WONG, S ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1348-1354
[7]   TOPOLOGICAL ASYMMETRY OF PHOSPHOLIPIDS IN MEMBRANES [J].
BERGELSON, LD ;
BARSUKOV, LI .
SCIENCE, 1977, 197 (4300) :224-230
[8]   ROUTES OF QUINOLONE PERMEATION IN ESCHERICHIA-COLI [J].
CHAPMAN, JS ;
GEORGOPAPADAKOU, NH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (04) :438-442
[9]   ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].
COHEN, SP ;
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
MCMURRY, LM ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191
[10]   INTRAPHAGOCYTIC KILLING OF SALMONELLA-TYPHIMURIUM BY LIPOSOME-ENCAPSULATED CEPHALOTHIN [J].
DESIDERIO, JV ;
CAMPBELL, SG .
JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (03) :563-570